Register Now: IKRIS Breast Cancer Awareness Run 2022

Featured Post

2 mins read

Ikris Pharma Network- A Generic Medication Supplier

The demand for generic medicines is increasing at the global level and pharmaceutical companies are realising the huge potential this […]

ikrisuser
July 19, 2021
2 mins read

Combination of Pembrolizumab Plus cCRT Demonstrated Promising Outcomes in Patients with Unresectable, Locally Advanced NSCLC

According to follow up data presented at the International Association for the Study of Lung Cancer 2020 World Conference on […]

ikrisuser
July 15, 2021
2 mins read

Metastatic Breast Cancer in Bones

Metastatic breast cancer in the bones refers to cancer that occurs from breast tissue and has spread to the bones. […]

ikrisuser
June 9, 2021
4 mins read

Ribociclib plus Endocrine Therapy demonstrated improved overall survival in advanced HR+/HER2- Breast Cancer

According to findings from an exploratory analysis of the Phase-III MONALEESA-7 trial presented during the 2021 ESMO Breast Cancer Virtual […]

ikrisuser
June 9, 2021
3 mins read

Tofacitinib for Ankylosing Spondylitis

According to Atul Deodhar, MD, MRCP, of Oregon Health & Science University, in Portland, Oregon, and colleagues, “Tofacitinib, an oral […]

ikrisuser
June 3, 2021
3 mins read

How Immunokris will help in Boosting Immune System

The immune system is specifically a network of cells, tissues, and organs that primarily work together in order to defend […]

ikrisuser
June 1, 2021
4 mins read

How Risky is Black Fungus? What are the Symptoms and Treatment?

COVID-associated black fungus has especially affected individuals in India. The association also appeared in Russia. One elaboration for why the […]

ikrisuser
May 24, 2021
2 mins read

World Health Organization to begin clinical trial on new repurposed drugs for severe cases of COVID-19

‘Solidarity’, an international clinical trial launched by the World Health Organization in order to help investigate an absolutely effective treatment […]

ikrisuser
May 17, 2021
4 mins read

Teclistamab Shows High Response Rate and Good Tolerability Profile in Patients with Multiple Myeloma

According to outcomes from an ongoing study presented during the II’nd European Myeloma Network Meeting, Teclistamab shows high response rate […]

ikrisuser
April 21, 2021
3 mins read

Afatinib (Gilotrif) Efficacious in the EGFR+ NSCLC With Uncommon Mutations, Regardless of Ethnicity

According to outcomes from a pooled analysis cane during the 2020 IASLC North America Conference on Lung Cancer, afatinib was […]

ikrisuser
April 20, 2021
We Offer You

Partnership

We love to partner with brands and products that we believe in. If you feel that your company shares values and would benefit our readers, we would love to talk about working together.

Learn More